{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T17:34:22Z","timestamp":1768066462847,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.preghy.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:50:00Z","timestamp":1649850600000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction"],"prefix":"10.1016","volume":"28","author":[{"given":"Lisa Antonia","family":"Lorenz-Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Sroka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Busjahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Verlohren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl A","key":"10.1016\/j.preghy.2022.04.002_b0005","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.preghy.2022.04.002_b0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.preghy.2022.04.002_b0015","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.preghy.2022.04.002_b0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.preghy.2022.04.002_b0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2022.04.002_b0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preghy.2017.02.005","article-title":"Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1\/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor\u00ae","volume":"8","author":"Dr\u00f6ge","year":"2017","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2022.04.002_b0035","doi-asserted-by":"crossref","unstructured":"Herraiz I, Dr\u00f6ge LA, G\u00f3mez-Montes E, Henrich W, Galindo A, Verlohren S. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction: Obstetr. Gynecol. 2014;124(2, PART 1):265-273. doi:10.1097\/AOG.0000000000000367.","DOI":"10.1097\/AOG.0000000000000367"},{"issue":"4","key":"10.1016\/j.preghy.2022.04.002_b0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/10641955.2013.827205","article-title":"Automated measurement of sFlt1, PlGF and sFlt1\/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders","volume":"32","author":"Engels","year":"2013","journal-title":"Hypertens. Pregnancy"},{"issue":"4","key":"10.1016\/j.preghy.2022.04.002_b0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/pd.4554","article-title":"Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia: Preeclampsia, angiogenic factors and risk of adverse outcomes","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenatal. Diagnosis"},{"issue":"2","key":"10.1016\/j.preghy.2022.04.002_b0050","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am. J. Obstetr. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2022.04.002_b0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2022.04.002_b0060","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am. J. Obstetr. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2022.04.002_b0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (Soluble fms-like tyrosine kinase 1)\/PlGF (Placental Growth Factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2022.04.002_b0070","doi-asserted-by":"crossref","unstructured":"McDonald CR, Darling AM, Liu E, et al. Angiogenic proteins, placental weight and perinatal outcomes among pregnant women in Tanzania. Robboy SJ, ed. PLoS ONE. 2016;11(12):e0167716. doi:10.1371\/journal.pone.0167716.","DOI":"10.1371\/journal.pone.0167716"},{"issue":"6","key":"10.1016\/j.preghy.2022.04.002_b0075","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/jcb.25789","article-title":"Placental-specific overexpression of sFlt-1 alters trophoblast differentiation and nutrient transporter expression in an IUGR mouse model","volume":"118","author":"K\u00fchnel","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.preghy.2022.04.002_b0080","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1080\/14767058.2019.1636371","article-title":"Placental weight and size in relation to fetal growth restriction: a case-control study","volume":"34","author":"Liu","year":"2021","journal-title":"J. Maternal-Fetal Neonatal Med."},{"issue":"6","key":"10.1016\/j.preghy.2022.04.002_b0085","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/00016340802056178","article-title":"Placenta weight in pre-eclampsia","volume":"87","author":"Dahlstr\u00f8m","year":"2008","journal-title":"Acta Obstetr. Gynecol. Scand."},{"issue":"3","key":"10.1016\/j.preghy.2022.04.002_b0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/uog.14760","article-title":"Maternal serum sFlt-1\/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies","volume":"45","author":"Dr\u00f6ge","year":"2015","journal-title":"Ultrasound Obstetr. Gynecol."},{"key":"10.1016\/j.preghy.2022.04.002_b0095","doi-asserted-by":"crossref","unstructured":"Stepan H, Kuse-F\u00f6hl S, Klockenbusch W, et al. Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No.\u2009015\/018, December 2013). Geburtshilfe Frauenheilkd. 2015;75(9):900-914. doi:10.1055\/s-0035-1557924.","DOI":"10.1055\/s-0035-1557924"},{"issue":"2","key":"10.1016\/j.preghy.2022.04.002_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"11","key":"10.1016\/j.preghy.2022.04.002_b0105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1055\/s-0043-118908","article-title":"Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015\/080, October 2016)","volume":"77","author":"Kehl","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.preghy.2022.04.002_b0110","unstructured":"Nicolaides K, Rizzo G, Hecher K, Ximenes R. Doppler in Obstetrics:162."},{"issue":"43","key":"10.1016\/j.preghy.2022.04.002_b0115","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Software"},{"issue":"1","key":"10.1016\/j.preghy.2022.04.002_b0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.placenta.2010.10.008","article-title":"Placenta weight percentile curves for singleton and twins deliveries","volume":"32","author":"Almog","year":"2011","journal-title":"Placenta"},{"issue":"12","key":"10.1016\/j.preghy.2022.04.002_b0125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/jcp.2008.055236","article-title":"The placenta in pre-eclampsia and intrauterine growth restriction","volume":"61","author":"Roberts","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.preghy.2022.04.002_b0130","unstructured":"Park S-Y, Kim MY, Kim YJ, et al. Placental Pathology in Intrauterine Growth Retardation:8."},{"issue":"3","key":"10.1016\/j.preghy.2022.04.002_b0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/uog.13310","article-title":"Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia: UtA Doppler, birth weight and pre-eclampsia","volume":"44","author":"Verlohren","year":"2014","journal-title":"Ultrasound Obstetr. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2022.04.002_b0140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/uog.7308","article-title":"Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A","volume":"34","author":"Proctor","year":"2009","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2022.04.002_b0145","article-title":"Large placenta and small foetus at early gestation predicts foetal growth restriction due to placental dysmorphology","author":"Poojari","year":"2018","journal-title":"JCDR Published online"},{"issue":"6","key":"10.1016\/j.preghy.2022.04.002_b0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-0528.2007.01327.x","article-title":"Placenta weight percentile curves for singleton deliveries","volume":"114","author":"Thompson","year":"2007","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.preghy.2022.04.002_b0155","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajog.2004.02.023","article-title":"Updating reference values for placental weights in Northern Alberta","volume":"190","author":"Dy","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1\u20132","key":"10.1016\/j.preghy.2022.04.002_b0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejogrb.2005.10.032","article-title":"Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios","volume":"128","author":"Burkhardt","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"7","key":"10.1016\/j.preghy.2022.04.002_b0165","doi-asserted-by":"crossref","DOI":"10.1515\/jpm-2017-0093","article-title":"Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks\u2019 pregnancy in normotensive women","volume":"45","author":"Wataganara","year":"2017","journal-title":"J. Perinat. Med."},{"issue":"3","key":"10.1016\/j.preghy.2022.04.002_b0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.120.15338","article-title":"Total versus free placental growth factor levels in the pathogenesis of preeclampsia","volume":"76","author":"Lecarpentier","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2022.04.002_b0175","doi-asserted-by":"crossref","first-page":"636.e1","DOI":"10.1016\/j.ajog.2014.11.035","article-title":"Maternal circulating angiogenic factors in twin and singleton pregnancies","volume":"212","author":"Faupel-Badger","year":"2015","journal-title":"Am. J. Obstetr. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2022.04.002_b0180","doi-asserted-by":"crossref","first-page":"428.e1","DOI":"10.1016\/j.ajog.2007.10.783","article-title":"Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?","volume":"198","author":"Bdolah","year":"2008","journal-title":"Am. J. Obstetr. Gynecol."},{"issue":"12","key":"10.1016\/j.preghy.2022.04.002_b0185","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14737159.2018.1546579","article-title":"An updated view on the origin and use of angiogenic biomarkers for preeclampsia","volume":"18","author":"Huppertz","year":"2018","journal-title":"Expert. Rev. Mol. Diagnost."},{"issue":"2","key":"10.1016\/j.preghy.2022.04.002_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2018.11.024","article-title":"Biology of preeclampsia: Combined actions of angiogenic factors, their receptors and placental proteins","volume":"1866","author":"Huppertz","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.preghy.2022.04.002_b0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10641955.2016.1273363","article-title":"Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies","volume":"36","author":"Hoeller","year":"2017","journal-title":"Hypertens. Pregnancy"},{"issue":"2","key":"10.1016\/j.preghy.2022.04.002_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10641955.2017.1291673","article-title":"Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia","volume":"36","author":"Ehrlich","year":"2017","journal-title":"Hypertens. Pregnancy"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:57:38Z","timestamp":1761897458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778922000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"alternative-id":["S2210778922000411"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2022.04.002","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}